Display options
Cite
Hiura M, Onizuka R, Narita R, et al. A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy. Clin J Gastroenterol. 2010;3(5):254-8doi: 10.1007/s12328-010-0171-z.
Hiura, M., Onizuka, R., Narita, R., Abe, S., Tabaru, A., & Harada, M. (2010). A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy. Clinical journal of gastroenterology, 3(5), 254-8. https://doi.org/10.1007/s12328-010-0171-z
Hiura, Masaaki, et al. "A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy." Clinical journal of gastroenterology vol. 3,5 (2010): 254-8. doi: https://doi.org/10.1007/s12328-010-0171-z
Hiura M, Onizuka R, Narita R, Abe S, Tabaru A, Harada M. A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy. Clin J Gastroenterol. 2010 Oct;3(5):254-8. doi: 10.1007/s12328-010-0171-z. Epub 2010 Sep 16. PMID: 26190331.
Copy Download .nbib Format: NLM
Share it on

Clin J Gastroenterol. 2010 Oct;3(5):254-8. doi: 10.1007/s12328-010-0171-z. Epub 2010 Sep 16.

A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy.

Clinical journal of gastroenterology

Masaaki Hiura, Ryo Onizuka, Ryoichi Narita, Shintaro Abe, Akinari Tabaru, Masaru Harada

Affiliations

  1. Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan. [email protected].
  2. Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan School of Medicine, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan.

PMID: 26190331 DOI: 10.1007/s12328-010-0171-z

Abstract

A 59-year-old male patient underwent surgical treatment for non-Hodgkin's lymphoma of the right scrotum in October 2007. He received a total of 4 courses of two different adjuvant chemotherapy regimens including rituximab from January to April 2008. In June 2008 he was hospitalized due to severe liver dysfunction with an alanine aminotransferase of 2039 IU/l and a prothrombin time of 23.3%. He was diagnosed with acute hepatitis C by the detection of hepatitis C virus (HCV) RNA and negative anti-HCV antibody, and his hepatic function improved with bed rest during hospitalization; however, the production of anti-HCV antibodies was not detected until January 2009. Severe liver dysfunction is uncommon among patients with acute hepatitis C, and the long window (8 months) between HCV infection and the development of anti-HCV antibodies observed in the present case may have been due, at least in part, to a B cell disorder caused by rituximab therapy. In addition to the well-known risk of reactivation of hepatitis B virus infection in patients undergoing chemotherapy, physicians should be aware of the potential effects of chemotherapy on the clinical course of HCV infection.

Keywords: Acute hepatitis; Hepatitis C virus; Humoral immunity; Rituximab

References

  1. Semin Hematol. 2010 Apr;47(2):187-98 - PubMed
  2. Gastroenterology. 1991 Jan;100(1):182-8 - PubMed
  3. Clin Liver Dis. 2008 Aug;12(3):693-712, x - PubMed
  4. Infection. 2010 Feb;38(1):58-61 - PubMed
  5. N Engl J Med. 1996 Jun 27;334(26):1685-90 - PubMed
  6. Antiviral Res. 2010 Jan;85(1):303-15 - PubMed
  7. Br J Haematol. 2002 Oct;119(1):279-80 - PubMed
  8. J Gastroenterol. 2001 Dec;36(12):799-808 - PubMed
  9. Annu Rev Pathol. 2006;1:23-61 - PubMed
  10. Expert Rev Mol Med. 2008 Oct 20;10:e30 - PubMed
  11. J Clin Oncol. 2009 Feb 1;27(4):605-11 - PubMed
  12. Blood. 2000 Aug 1;96(3):1184-6 - PubMed
  13. N Engl J Med. 2001 Sep 27;345(13):1000 - PubMed
  14. Eur J Haematol. 2008 May;80(5):381-5 - PubMed
  15. J Gen Virol. 2003 Jan;84(Pt 1):139-46 - PubMed
  16. Lancet. 2008 Jul 26;372(9635):321-32 - PubMed
  17. Clin Immunol. 2008 Aug;128(2):133-47 - PubMed
  18. Clin Rev Allergy Immunol. 2008 Feb;34(1):111-7 - PubMed
  19. Drugs. 1999 Jul;58(1):79-88; discussion 89-90 - PubMed
  20. Gastroenterology. 2006 Jul;131(1):59-68 - PubMed
  21. J Clin Oncol. 2004 Mar 1;22(5):927-34 - PubMed
  22. Am J Hematol. 2008 Jan;83(1):59-62 - PubMed
  23. N Engl J Med. 2002 Jan 24;346(4):235-42 - PubMed
  24. J Clin Oncol. 2006 Feb 20;24(6):953-60 - PubMed
  25. Hematol J. 2003;4(2):159-62 - PubMed
  26. J Clin Oncol. 1998 Aug;16(8):2825-33 - PubMed
  27. Gastroenterology. 2003 Dec;125(6):1742-9 - PubMed
  28. J Clin Oncol. 1997 Apr;15(4):1567-74 - PubMed

Publication Types